Long-Term Gender-Based Outcomes for Atazanavir/Ritonavir (ATV/r)- Containing Regimens in Treatment-Experienced Patients with HIV

By  

Current HIV Research, Vol. 11, Iss. 4, 2013-06 ,pp. : 333-341

Bentham Science Publishers

Access to resources Recommend Favorite

HIV-1 Drug Susceptibility to Potential Second- and Third-Line Antiretroviral Regimens among Cameroonian Patients: Evidence from a Crosssectional Design

By  

Current HIV Research, Vol. 15, Iss. 1, 2017-01 ,pp. : 66-73

Bentham Science Publishers

Access to resources Recommend Favorite

The influence of the patients' educational levels on socioeconomic, clinical, immunological and virological endpoints

By Collazos Julio   Asensi Victor   Carton Jose Antonio   Ibarra Sofia  

AIDS Care, Vol. 21, Iss. 4, 2009-04 ,pp. : 511-519

Routledge Ltd

Access to resources Recommend Favorite

Twelve week post-treatment undetectable hepatitis C virus (HCV)-RNA by PCR assay predicts a sustained virological response to anti-HCV therapy independently from immunological status of the infected patients

By Donato Maria Francesca   Bastiampillai Anan Judina   Manini Matteo   Monico Sara  

Journal of Antimicrobial Chemotherapy, Vol. 68, Iss. 4, 2013-04 ,pp. : 974-975

Oxford University Press

Access to resources Recommend Favorite

Pooled Analysis on the Efficacy of the Second-line Treatment Regimens for Helicobacter pylori Infection

By Hojo M.   Miwa H.   Nagahara A.   Sato N.  

Scandinavian Journal of Gastroenterology, Vol. 36, Iss. 7, 2001-07 ,pp. : 690-700

Informa Healthcare

Access to resources Recommend Favorite